Same drug, different label, wildly different pricing pathways. Ozempic and Wegovy both contain semaglutide made by Novo Nordisk. Ozempic is approved for type 2 diabetes (max 2mg). Wegovy is approved for weight loss (max 2.4mg). If you have diabetes or prediabetes, Ozempic is often easier and cheaper to get covered. For everyone else, Wegovy's self-pay options — especially the new $149/month oral pill — make it the clear winner.
If you've been researching GLP-1 medications, you've probably noticed something confusing: Ozempic and Wegovy look suspiciously similar. That's because they are. Same active ingredient. Same manufacturer. Same injection mechanism. Same molecule.
The differences that matter are on the label, in the dosing, and most critically, in your wallet.
Same Drug, Different Labels
| Factor | Ozempic | Wegovy |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Manufacturer | Novo Nordisk | Novo Nordisk |
| FDA indication | Type 2 diabetes | Chronic weight management |
| Additional indication | — | CV risk reduction ✓ |
| Max weekly dose | 2.0 mg | 2.4 mg ✓ |
| Available formats | Injectable pen | Injectable pen + oral pill ✓ |
| Year approved | 2017 | 2021 |
The Price Breakdown
This is where the real differences emerge — and where smart patients can save thousands per year.
| Pricing Pathway | Ozempic | Wegovy |
|---|---|---|
| Retail list price | $935/mo | $1,349/mo |
| Self-pay (NovoCare) | ~$300-400/mo | $349/mo (injectable) |
| Oral pill price | N/A | $149/mo ✓ |
| Insurance for diabetes | Broadly covered ✓ | Rarely covered for diabetes |
| Insurance for weight loss | Off-label (denied) | Possible (with PA) |
| Savings card (insured) | As low as $25/mo | As low as $0/mo |
| Medicare | Part D for diabetes ✓ | CV indication pathway |
The key insight: If you have type 2 diabetes or prediabetes, Ozempic prescribed for your diabetes — which also happens to help you lose weight — is often the cheapest path. Your insurer is far more likely to cover a diabetes medication than a weight loss medication. Ask your doctor about this strategy.
Off-Label Ozempic for Weight Loss
Millions of people use Ozempic off-label for weight loss. Doctors can legally prescribe it for any purpose they deem medically appropriate, even if the FDA approval is specifically for type 2 diabetes.
However, there are real drawbacks to this approach:
Insurance almost never covers it. If you don't have a diabetes diagnosis, your insurer will deny Ozempic claims. You'll pay full self-pay pricing.
The dose tops out at 2.0mg. Wegovy goes up to 2.4mg — that extra 0.4mg per week produces meaningfully more weight loss in clinical trials. The STEP trials used the 2.4mg dose; the weight loss numbers you see cited for semaglutide are based on Wegovy's dosing, not Ozempic's.
Wegovy's oral pill changes the math. At $149/month for brand-name Wegovy in pill form, paying out-of-pocket for off-label Ozempic at $300-400/month makes no financial sense unless you specifically need the injectable.
When Ozempic Is the Better Choice
You have type 2 diabetes or prediabetes. This is the clear scenario for Ozempic. Insurance coverage for diabetes medications is strong, and with a manufacturer savings card, your copay could be $25-50/month.
Your A1C is elevated. Even without a formal diabetes diagnosis, an A1C of 5.7-6.4% (prediabetes range) gives your doctor clinical justification to prescribe Ozempic for glycemic control — which makes insurance far more likely to cover it.
You already have insulin resistance or metabolic syndrome. These comorbidities strengthen the case for semaglutide as a metabolic medication, not just a weight loss drug.
When Wegovy Is the Better Choice
Weight loss is your primary goal and you're metabolically healthy. Without a diabetes or prediabetes diagnosis, Wegovy is the correct on-label prescription for chronic weight management.
You want the oral option. Wegovy is the only brand-name GLP-1 available in pill form for weight loss. At $149/month, it's a game-changer for people who dislike injections or want the lowest-cost brand-name option.
You want the higher dose. Wegovy's 2.4mg weekly dose delivers meaningfully more weight loss than Ozempic's 2.0mg max. If you've plateaued on Ozempic, switching to Wegovy gives your doctor room to increase.
You need the cardiovascular indication. Wegovy's FDA-approved CV risk reduction indication opens insurance pathways — including some Medicare coverage — that Ozempic's diabetes-only label can't access for weight management purposes.
Find the Best Price for Brand-Name Semaglutide
Sesame Care offers transparent self-pay pricing for both Wegovy and Ozempic with licensed providers. No hidden fees.
Check Sesame Care Pricing →Affiliate link · Prices verified March 2026
The Compounded Option
If neither Ozempic nor Wegovy fits your budget, compounded semaglutide from licensed telehealth platforms typically costs $146-250/month — significantly less than either brand-name option.
Compounded semaglutide is the same active molecule, prepared by licensed 503A or 503B compounding pharmacies. It's not FDA-approved as a specific product, but it's prepared by licensed pharmacies operating under FDA enforcement discretion. See our brand vs. compounded comparison for the full breakdown.
Quick Decision Framework
| Your Situation | Best Option | Expected Monthly Cost |
|---|---|---|
| Diabetes + insurance | Ozempic (on-label) | $25-50 with savings card |
| Prediabetes + insurance | Ozempic (via prediabetes dx) | $25-100 |
| Weight loss + insurance covers Wegovy | Wegovy (on-label) | $0-50 with savings card |
| Weight loss + no insurance coverage | Wegovy oral pill | $149/mo |
| Budget-focused, any situation | Compounded semaglutide | $146-250/mo |
Don't let the complexity of GLP-1 pricing keep you from starting treatment. The landscape has more affordable options than ever — you just need to know which pathway fits your situation.